Portfolio company
Spot Biosystems
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Sonothera Therapeutics
This company develops a non-viral gene therapy platform using ultrasound and microbubbles to deliver genetic medicines for patients with serious diseases.
Chameleon Biosciences
This company develops immune-evading gene therapy delivery platforms for pharmaceutical firms and patients with genetic disorders.
Anjarium BioSciences
This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
SonoThera™
This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.
Immitra Bio
This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.
